20/20 Biolabs, Inc. (AIDX) Balance Sheet
AIDX balance sheet, 2025
December 31, 2025 · U.S. dollars$4.1M assets = $4.2M liabilities + −$19,225 equity
Liabilities exceed assets: shareholders’ equity is negative (−$19,225).
Both columns are drawn to the same scale: what AIDX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AIDX financial health
Descriptive bands, not a rating. Fiscal 2025.
AIDX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.3M2016 | $4.1M2025 | +13.3%/yr | |
| Total liabilities | $561,9532016 | $4.2M2025 | +24.9%/yr | |
| Shareholders’ equity | $784,3612016 | −$19,2252025 | — | |
| Cash & short-term investments | $982,2252016 | $1.03B2025 | +116.5%/yr | |
| Total debt | $144,1072020 | $1.28B2025 | +516.6%/yr | |
| Net cash (debt) | $3.3M2020 | −$258.0M2025 | −$261.4M | |
| Working capital | $525,9272016 | −$992,0082025 | −$1.5M | |
| Book value per share | $0.172016 | −$0.002025 | — | |
| Current ratio | 1.942016 | 0.602025 | −1.34 | |
| Debt / equity | 0.042020 | 0.992024 | +0.94 | |
| Shares outstanding | 4.6M2016 | 6.3M2025 | +3.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AIDX assets
AIDX liabilities and equity
AIDX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AIDX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $1.03B | $1.8M | $4.1M | $8.8M | $3.4M | $3.5M | $2.3M | $3.3M | $1.0M | $982,225 |
| Cash & equivalents | $1.03B | $1.8M | $4.1M | $8.8M | $3.4M | $3.5M | $636,018 | $3.3M | $1.0M | $982,225 |
| Short-term investments | — | — | — | — | — | — | $1.6M | — | — | — |
| Receivables | $200.0M | $135,272 | $68,834 | $764,924 | $4.2M | $205,071 | $32,498 | $15,488 | $53,106 | $44,217 |
| Inventory | $116.2M | $47,164 | $60,668 | $87,074 | $246,658 | $103,441 | $35,477 | $26,298 | $37,792 | $43,864 |
| Other current assets | $0 | $67,780 | $81,469 | $72,270 | $125,664 | $50,165 | $51,567 | $16,478 | $11,019 | $16,074 |
| Total current assets | $1.5M | $2.0M | $4.3M | $9.7M | $7.9M | $3.8M | $2.4M | $3.3M | $1.1M | $1.1M |
| Property, plant & equipment (net) | $662.0M | $889,054 | $1.2M | $1.7M | $1.7M | $205,006 | $48,924 | $60,994 | $7,017 | $16,032 |
| Goodwill & intangible assets | $202.3M | $499,172 | $526,529 | $726,841 | $581,598 | $620,882 | $658,024 | $641,995 | $200,559 | $178,517 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $190,691 | $363,270 | $86,643 | $68,046 | $24,617 | $15,572 | $70,462 | $72,545 | $65,385 |
| Total assets | $4.1M | $3.6M | $6.4M | $12.2M | $10.3M | $4.7M | $3.1M | $4.1M | $1.4M | $1.3M |
| Liabilities | ||||||||||
| Accounts payable | $868.5M | $372,303 | $360,279 | $464,282 | $834,269 | $471,056 | $382,722 | $327,668 | $254,440 | $134,437 |
| Short-term debt | $176.1M | $165,702 | $163,788 | $199,872 | $145,028 | $103,860 | — | — | — | — |
| Deferred revenue | $414.9M | $470,451 | $254,871 | $316,222 | $152,698 | $70,456 | $77,775 | — | $210,000 | $688 |
| Total current liabilities | $2.5M | $1.4M | $1.0M | $1.6M | $2.3M | $1.2M | $976,560 | $820,542 | $964,437 | $560,453 |
| Long-term debt | $619,355 | $0 | $229,164 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $664,673 | $839,550 | $1.0M | — | — | — | — | — | — | — |
| Other long-term liabilities | $1.1M | $723,848 | $839,549 | $1.2M | $1.1M | $40,246 | $0 | $0 | $1,500 | $1,500 |
| Total liabilities | $4.2M | $2.1M | $2.1M | $2.8M | $3.4M | $1.3M | $976,560 | $820,542 | $965,937 | $561,953 |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $54,422 | $48,231 | $47,731 | $47,648 | $47,626 | $47,288 | $47,256 | $47,256 | $46,326 | $46,326 |
| Retained earnings (deficit) | −$33.2M | −$29.5M | −$24.0M | −$17.6M | −$19.8M | −$21.8M | −$19.8M | −$17.4M | −$15.9M | −$14.6M |
| Total shareholders' equity | −$19,225 | $1.5M | $4.3M | $9.4M | $6.9M | $3.4M | $2.1M | $3.3M | $456,184 | $784,361 |
| Key figures | ||||||||||
| Total debt | $1.28B | $1.5M | $2.1M | $2.4M | $2.4M | $144,107 | — | — | — | — |
| Net cash (debt) | −$258.0M | $270,611 | $2.0M | $6.4M | $1.0M | $3.3M | — | — | — | — |
| Working capital | −$992,008 | $679,147 | $3.3M | $8.1M | $5.7M | $2.6M | $1.4M | $2.5M | $177,563 | $525,927 |
| Tangible book value | −$202.3M | $1.0M | $3.8M | $8.6M | $6.3M | $2.8M | $1.5M | $2.6M | $255,625 | $605,844 |
| Book value per share | −$0.00 | $0.32 | $0.90 | $0.99 | $0.73 | $0.72 | $0.45 | $0.70 | $0.10 | $0.17 |
| Shares outstanding | 6.3M | 4.8M | 4.8M | 9.5M | 9.5M | 4.7M | 4.7M | 4.7M | 4.6M | 4.6M |
| Current ratio | 0.60 | 1.50 | 4.25 | 5.97 | 3.52 | 3.07 | 2.46 | 4.06 | 1.18 | 1.94 |
| Quick ratio | 497.71 | 1.42 | 4.11 | 5.87 | 3.36 | 2.94 | 2.37 | 4.01 | 1.13 | 1.83 |
| Debt / equity | — | 0.99 | 0.48 | 0.26 | 0.34 | 0.04 | — | — | — | — |
| Equity / assets | −0.5% | 42.5% | 67.3% | 76.7% | 67.1% | 72.5% | 68.8% | 80.0% | 32.1% | 58.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Dec '24 | Dec '23 | Sep '23 | Jun '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $4.5M | $4.2M | $1.03B | $1.1M | $1.0M | $1.8M | $4.1M | $4.1M | $6.2M |
| Cash & equivalents | $4.5M | $4.2M | $1.03B | $1.1M | $1.0M | $1.8M | $4.1M | $4.1M | $6.2M |
| Receivables | $291,486 | $201,481 | $200.0M | $136,873 | $174,251 | $135,272 | $68,834 | $68,834 | $223,951 |
| Inventory | $111,036 | $104,523 | $116.2M | $54,762 | $61,660 | $47,164 | $60,668 | $60,668 | $73,700 |
| Other current assets | $126,961 | $175,174 | $0 | $229,284 | $152,909 | $67,780 | $81,469 | $81,469 | $162,134 |
| Total current assets | $5.1M | $4.7M | $1.5M | $1.6M | $1.4M | $2.0M | $4.3M | $4.3M | $6.7M |
| Property, plant & equipment (net) | $553,000 | $607,694 | $662.0M | $718,034 | $774,625 | $889,054 | $1.2M | $1.2M | $1.3M |
| Goodwill & intangible assets | $205,985 | $472,319 | $202.3M | $479,848 | $486,289 | $499,172 | $526,529 | $526,529 | $525,307 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $288,577 | $23,057 | $0 | $475,793 | $23,057 | $190,691 | $363,270 | $363,270 | $325,132 |
| Total assets | $6.1M | $5.8M | $4.1M | $3.2M | $2.7M | $3.6M | $6.4M | $6.4M | $8.8M |
| Liabilities | |||||||||
| Accounts payable | $1.0M | $980,486 | $868.5M | $628,384 | $556,636 | $372,303 | $360,279 | $360,279 | $419,014 |
| Short-term debt | $192,731 | $496,365 | $176.1M | $173,349 | $170,781 | $165,702 | $163,788 | $163,788 | $174,186 |
| Deferred revenue | $467,033 | $450,667 | $414.9M | $508,788 | — | $470,451 | — | — | $353,789 |
| Total current liabilities | $2.6M | $2.6M | $2.5M | $2.0M | $1.6M | $1.4M | $1.0M | $1.0M | $1.1M |
| Long-term debt | $0 | $0 | $619,355 | $450,498 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $572,448 | $618,771 | $664,673 | $709,308 | — | $839,550 | — | — | — |
| Other long-term liabilities | $412,641 | $466,177 | $1.1M | $688,343 | $699,843 | $723,848 | $1.1M | $1.1M | $1.1M |
| Total liabilities | $3.0M | $3.0M | $4.2M | $3.1M | $2.3M | $2.1M | $2.1M | $2.1M | $2.3M |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $122,512 | $104,430 | $54,422 | $49,172 | $48,231 | $48,231 | $47,731 | $47,731 | $47,653 |
| Retained earnings (deficit) | −$36.9M | −$35.4M | −$33.2M | −$31.9M | −$30.7M | −$29.5M | −$24.0M | −$24.0M | −$21.3M |
| Total shareholders' equity | $3.2M | $2.8M | −$19,225 | $108,456 | $351,609 | $1.5M | $4.3M | $4.3M | $6.6M |
| Key figures | |||||||||
| Total debt | $572,448 | $925,487 | $1.28B | $1.7M | $824,791 | $1.5M | $1.2M | $1.2M | $2.2M |
| Net cash (debt) | $4.0M | $3.3M | −$258.0M | −$550,910 | $199,158 | $270,611 | $2.9M | $2.9M | $4.0M |
| Working capital | $2.5M | $2.1M | −$992,008 | −$426,378 | −$232,519 | $679,147 | $3.3M | $3.3M | $5.6M |
| Tangible book value | $3.0M | $2.3M | −$202.3M | −$371,392 | −$134,680 | $1.0M | $3.8M | $3.8M | $6.1M |
| Book value per share | $0.29 | $0.26 | −$0.00 | $0.02 | — | $0.32 | — | — | $1.38 |
| Shares outstanding | 10.8M | 10.6M | 10.4M | 4.9M | — | 4.8M | — | — | 4.8M |
| Current ratio | 1.99 | 1.82 | 0.60 | 0.79 | 0.86 | 1.50 | 4.25 | 4.25 | 6.00 |
| Quick ratio | 1.90 | 1.71 | 497.71 | 0.64 | 0.73 | 1.42 | 4.11 | 4.11 | 5.79 |
| Debt / equity | 0.18 | 0.34 | — | 15.64 | 2.35 | 0.99 | 0.29 | 0.29 | 0.34 |
| Equity / assets | 51.6% | 47.5% | −0.5% | 3.3% | 13.0% | 42.5% | 67.3% | 67.3% | 74.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
AIDX financial position
At the end of fiscal 2025 (December 31, 2025), 20/20 Biolabs had total assets of $4.1 million (up 14.5% from a year earlier), total liabilities of $4.2 million and shareholders' equity of -$0.0 million. It held $1.0 billion in cash and short-term investments against $1.3 billion of debt, net debt of $258.0 million. Its current ratio was 0.60. In the latest quarter (ended June 30, 2026) total assets were $6.1 million and equity $3.2 million.
Related: AIDX income statement, AIDX cash flow statement, AIDX key metrics. See the AIDX stock overview for the latest quote and news.
AIDX balance sheet FAQ
What are 20/20 Biolabs's total assets?
20/20 Biolabs reported total assets of $4.1 million at the end of fiscal 2025 (December 31, 2025), compared with $3.6 million a year earlier.
How much debt does 20/20 Biolabs have?
20/20 Biolabs had $1.3 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.
How much cash does 20/20 Biolabs have?
20/20 Biolabs held $1.0 billion in cash and short-term investments at the end of fiscal 2025; with $1.3 billion of debt that is net debt of $258.0 million.
What is 20/20 Biolabs's book value?
20/20 Biolabs's shareholders' equity (book value) was -$0.0 million at the end of fiscal 2025, or −$0.00 per share.
What is 20/20 Biolabs's current ratio?
20/20 Biolabs had current assets of $1.5 million and current liabilities of $2.5 million, a current ratio of 0.60 (current liabilities exceed current assets).
How much goodwill does 20/20 Biolabs have?
20/20 Biolabs carried $202.3 million of goodwill and intangible assets, 4,888.7% of total assets, at the end of fiscal 2025.